Authors: BRYANT SG

Citation: Sg. Bryant, REASSESSMENT OF NEFAZODONE, American journal of health-system pharmacy, 53(19), 1996, pp. 2339-2340

Authors: FISHER S KENT TA BRYANT SG

Citation: S. Fisher et al., POSTMARKETING SURVEILLANCE BY PATIENT SELF-MONITORING - PRELIMINARY DATA FOR SERTRALINE VERSUS FLUOXETINE, The Journal of clinical psychiatry, 56(7), 1995, pp. 288-296

Authors: FISHER S BRYANT SG KENT TA DAVIS JE

Citation: S. Fisher et al., PATIENT DRUG ATTRIBUTIONS AND POSTMARKETING SURVEILLANCE, Pharmacotherapy, 14(2), 1994, pp. 202-209

Authors: SANTY PA BRYANT SG

Citation: Pa. Santy et Sg. Bryant, TEACHING CLINICAL PSYCHOPHARMACOLOGY ON AN INPATIENT PSYCHIATRIC RESEARCH-CENTER, Journal of clinical pharmacology, 34(3), 1994, pp. 215-221

Authors: ASCONAPE JJ LANCMAN ME BROTHERTON TA BRYANT SG GIBSON PA PENRY JK

Citation: Jj. Asconape et al., PSYCHOGENIC SEIZURES - A COMPARISON BETWEEN CHILDREN AND ADULTS, Neurology, 44(4), 1994, pp. 10000140-10000140

Authors: FISHER S BRYANT SG KENT TA

Citation: S. Fisher et al., POSTMARKETING SURVEILLANCE BY PATIENT SELF-MONITORING - TRAZODONE VERSUS FLUOXETINE, Journal of clinical psychopharmacology, 13(4), 1993, pp. 235-242